News

Filter

Current filters:

OralairLicensing

1 to 9 of 96136 results

Room for new products in metastatic prostate cancer treatment market, says GlobalData

Room for new products in metastatic prostate cancer treatment market, says GlobalData

17-09-2014

Although many new products have been launched since 2010 to treat metastatic castration-resistant prostate…

GlobalDataOncologyPharmaceuticalProductionResearchXtandiZytiga

Sanofi and MyoKardia ink deal for genetic heart disease research

Sanofi and MyoKardia ink deal for genetic heart disease research

17-09-2014

French pharma major Sanofi has signed a global collaboration with privately-held US firm MyoKardia to…

Cardio-vascularGlobalLicensingMyoKardiaPharmaceuticalResearchSanofi

Denovo Biopharma acquires Lilly’s enzastaurin for development as a personalized medicine

Denovo Biopharma acquires Lilly’s enzastaurin for development as a personalized medicine

17-09-2014

Privately-held San Diego, USA-based biotech firm Denovo Biopharma has acquired enzastaurin, a late-stage…

BiotechnologyDenovo BiopharmaEli LillyenzastaurinGlobalLicensingOncology

Political developments impacting medicines for Russia

Political developments impacting medicines for Russia

17-09-2014

Russia's pharmaceutical market has been growing faster over recent years. The Pharma 2020 Strategy provides…

Markets & MarketingPharmaceuticalPoliticsRussia

First therapy under UK’s early access scheme to be Northwest Biotherapeutics’ DCVax-L

First therapy under UK’s early access scheme to be Northwest Biotherapeutics’ DCVax-L

17-09-2014

The UK’s Department of Health announced that DCVax-L, the dendritic cell-based vaccine from US company…

BiotechnologyDCVaxNorthwest BiotherapeuticsOncologyRegulationUK

Merck Serono to partner with Lupin for emerging market exposure

Merck Serono to partner with Lupin for emerging market exposure

17-09-2014

Merck Serono, the biotech unit of Germany’s Merck KGaA, has entered a strategic partnership with Indian…

Antibiotics and Infectious diseasesBiotechnologyCardio-vascularDiabetesGermanyIndiaLicensingLupinMerck KGaAMerck Serono

FDA approves AstraZeneca’s Movantik for opioid-induced constipation

FDA approves AstraZeneca’s Movantik for opioid-induced constipation

17-09-2014

The US Food and Drug Administration yesterday approved Movantik (naloxegol), an oral treatment for opioid-induced…

AstraZenecaGastro-intestinalsMovantikNektar TherapeuticsPharmaceuticalRegulationUSA

1 to 9 of 96136 results

Back to top